Womens Imaging

AIUM: Aspirin use in pregnancy not linked to fetal ductal constriction
By Amerigo Allegretto
Echocardiography shows that the use of low-dose aspirin during pregnancy is not tied to fetal ductal constriction.
March 30, 2025
Nkechinyelum Ogu, MD, presents her team’s findings showing that aspirin use among pregnant women is not tied to more severe fetal ductus arteriosus constriction and other complications.
AI speeds up fetal ultrasound scan times
By Amerigo Allegretto
AI could help sonographers find fetal abnormalities faster and with high accuracy.
March 28, 2025
Fetal Ultrasound
Do radiologists trust mammography AI software?
By Erik L. Ridley
A large-scale prospective trial exploring the use of mammography AI software in a breast cancer screening program has found that recalls were lower when cases were flagged by AI.
March 18, 2025
Full-field digital screening mammograms in participants recalled by the consensus discussion after being flagged by artificial intelligence (AI) computer-aided detection (CAD) but not by either of the two radiologists. (A) Mammogram with AI CAD score of 73 for a 55-year-old woman diagnosed with grade 3 in situ cancer and T1 (9-mm) invasive cancer in the left breast and lymph node metastasis. (B) Mammogram with AI CAD score of 54 for a 49-year-old woman diagnosed with grade 2 in situ cancer and T1 (6-mm) invasive cancer in the right breast and without lymph node metastasis. All images and caption courtesy of the RSNA.
Mammographic breast density not affected by multivitamins
By AuntMinnie.com staff writers
The use of multivitamin supplements has no influence on mammographic breast density, researchers have reported.
March 17, 2025
Breast Mammo 400
Surveillance may be used for DBT-detected architectural distortions
By Amerigo Allegretto
Imaging surveillance may be a safe alternative to surgery for architectural distortions detected on digital breast tomosynthesis (DBT) alone.
March 12, 2025
2025 03 12 Ajr Dbt Distortions Thumbnail
CEM improves breast cancer detection rate over low-energy mammography
By Amerigo Allegretto
Contrast-enhanced mammography (CEM) improves breast cancer detection over low-energy mammography in screening settings.
March 11, 2025
Images depict true-positive findings in a 51-year-old woman with a left breast focal nonmass enhancement. (A) Mediolateral oblique and (B) cranio-caudal contrast-enhanced mammographic (CEM) images show the enhancement (arrows). No correlate was identified on (C) mediolateral-oblique or (D) craniocaudal low-energy images, or whole-breast ultrasound (not shown). Contrast-enhanced breast MRI shows a suspicious enhancement on (E) sagittaland (F) axial subtraction images (arrows), correlating with the finding on CEM images. MRI-guided biopsy (not shown) showed flat epithelial atypia, withsubsequent surgery confirming ductal carcinoma in situ.
Cancer screening rates low among unhoused population
By Amerigo Allegretto
Cancer screening rates among the unhoused are low despite overall high willingness to be screened.
March 10, 2025
Dna Cancer Cell
'Social capital' tied to more screening mammography uptake
By Amerigo Allegretto
County-level social capital is linked to higher screening mammography rates.
March 7, 2025
Mammogram Breast 400
Deep-learning radiomics model aids in ovarian cancer diagnosis
By Amerigo Allegretto
An ensemble model combining clinical variables, O-RADS, and deep learning radiomics can diagnose ovarian tumors.
March 5, 2025
(A) SHAP summary plot shows the global contributions of variables to the model predictions. (B-E) Local explanation of the model for a single instance of ovarian endometrioid carcinoma: SHAP waterfall plot (B), ultrasound grayscale image (C), ultrasound color Doppler image (D), and 10×10 histopathological image (E). Images are available for republishing under a Creative Commons license (CC BY-NC-ND 4.0).
Breast, colorectal cancer screening numbers rebound post-COVID
By Amerigo Allegretto
Breast and colorectal cancer screening in 2023 rebounded from declines during the COVID-19 pandemic and surpassed prepandemic screening estimates.
March 5, 2025
Covid 19 Spread Usa 400 (1)
FES-PET shows promise staging patients with low-grade breast cancer
By Will Morton
F-18 fluoroestradiol (FES) PET may improve staging of grade 1 or 2 estrogen receptor-positive breast cancer compared with F-18 FDG-PET.
March 4, 2025
Fes Pet2 Thumbnail
Interventional breast radiology can boost sustainability efforts
By Amerigo Allegretto
Minimally invasive breast interventions can contribute to best sustainability practices, suggest presentations given at ECR 2025.
March 3, 2025
Breast Mammo
Page 1 of 683
Next Page